{"organizations": [], "uuid": "279ed9823df6c2bb6578835f33c1da37b459b421", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180517.html", "section_title": "Archive News &amp; Video for Thursday, 17 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-op-financial-ltd-reports-99-pct-st/brief-op-financial-ltd-reports-9-9-pct-stake-in-novabay-pharmaceuticals-as-of-feb-8-idUSFWN1SO10Q", "country": "US", "domain_rank": 408, "title": "BRIEF-OP Financial Ltd Reports 9.9 Pct Stake In NovaBay Pharmaceuticals As Of Feb 8", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-18T05:28:00.000+03:00", "replies_count": 0, "uuid": "279ed9823df6c2bb6578835f33c1da37b459b421"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-op-financial-ltd-reports-99-pct-st/brief-op-financial-ltd-reports-9-9-pct-stake-in-novabay-pharmaceuticals-as-of-feb-8-idUSFWN1SO10Q", "ord_in_thread": 0, "title": "BRIEF-OP Financial Ltd Reports 9.9 Pct Stake In NovaBay Pharmaceuticals As Of Feb 8", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "novabay pharmaceuticals inc", "sentiment": "negative"}, {"name": "brief-op financial ltd", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 17 (Reuters) - NovaBay Pharmaceuticals Inc:\n* OP FINANCIAL LTD REPORTS 9.9 PERCENT STAKE IN NOVABAY PHARMACEUTICALS INC AS OF FEB 8 - SEC FILING\n* OP FINANCIAL SAYS SHARES WERE ACQUIRED BASED ON BELIEF THAT SECURITIES OF NOVABAY PHARMACEUTICALS REPRESENTED \"ATTRACTIVE INVESTMENT OPPORTUNITY\" Source text: ( bit.ly/2GrxYXD ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/", "https://bit.ly/2GrxYXD"], "published": "2018-05-18T05:28:00.000+03:00", "crawled": "2018-05-18T19:51:38.000+03:00", "highlightTitle": ""}